SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is seeing heightened investor attention amid escalating Middle East tensions, following reports of a drone strike on Saudi Arabia's largest oil refinery and fears over the Strait of Hormuz. The community is actively discussing its potential for a significant short squeeze and a parabolic price run, drawing comparisons to past oil rallies driven by geopolitical events.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp. (BATL) is soaring amidst intense discussions surrounding escalating geopolitical tensions impacting Middle Eastern oil supply and shipping, leading to a surge in crude prices. The low-float oil producer is a focal point for traders anticipating a significant short squeeze due to high short interest and heightened market volatility.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing a massive price surge driven by strong earnings and bullish guidance for its 800G transceiver demand from hyperscale data centers, leading to multiple analyst upgrades in the optical networking sector. The community is keenly debating whether the stock's parabolic move reflects genuine long-term potential in AI infrastructure or if it's an overvalued pump-and-dump susceptible to dilution from a recent stock offering.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as the critical role of photonics in AI infrastructure draws intensified investor focus, evidenced by recent significant institutional stakes, though community sentiment remains split between high conviction in its optical interconnect technology and impatience for tangible commercialization ahead of the upcoming OFC conference.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

United States Oil Fund (USO) is surging amidst heightened geopolitical tensions from reported U.S.-Israeli strikes on Iran and subsequent retaliatory attacks, driving community discussion around severe oil supply disruptions if the Strait of Hormuz remains impacted, with many anticipating a significant price surge.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure (QURE) is trending sharply lower after the FDA indicated that Phase I/II data for its Huntington's disease gene therapy, AMT-130, are insufficient for approval, recommending a larger, sham-controlled Phase III trial. The community is actively debating this regulatory setback, questioning the FDA's "moving goalposts" and commitment to accelerating treatments for rare diseases.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending following a solid Q4 earnings beat and a new five-year LNG supply agreement with Trafigura, reinforcing its strong growth trajectory. The community is actively discussing the stock's significant undervaluation compared to its rapidly expanding LNG capacity, emphasizing its strategic advantage in the spot market amid escalating geopolitical tensions in the Strait of Hormuz, which could further drive up global LNG prices and potentially trigger a short squeeze.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Escalating geopolitical tensions in the Middle East, marked by drone strikes on key energy facilities and reports of shipping disruptions in the Strait of Hormuz, are fueling widespread speculation about rapidly rising oil prices. The community is largely bullish on Exxon Mobil, viewing it as a direct beneficiary of the heightened risk premium and anticipating significant upside for the broader energy sector.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is capturing market attention as escalating US-Iran tensions and potential disruptions in the Strait of Hormuz drive strong safe-haven flows, leading community discussion around gold's role as a critical hard asset during geopolitical uncertainty.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending due to a strategic agreement with NVIDIA, which includes a significant investment and commitment for advanced optical components, positioning the company as a key player in the expanding AI data center infrastructure, while community discussions highlight both significant upside and concerns about its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Penny Stocks To Follow Today - February 27th

OneMedNet, Ensysce Biosciences, and Banco Bradesco are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small companies that...

Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review

Ensysce Biosciences stock surged 58% after launching a strategic review to explore partnerships, licensing deals, or asset sales.read more...

Shares of Ensysce Biosciences, Inc. (ENSC) traded nearly 11% higher on Tuesday afternoon after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.ensysce.com/news/press-releases/detail/186/ensysce-biosciences-announces-positive-data-from-opioid">said</a> its PF614-MPAR pain relief medication demonstrated in a study that it can deliver strong relief for severe pain while protecting from the risk of excessive doses.The company completed the first part of its second clinical trial to evaluate PF614-MPAR for overdose protection. It confirmed that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.CEO Bill Schmidt said that the clinical data demonstrates the ability of the company’s Multi-Pill Abuse Resistance (MPAR) platform as a vital tool to limit overdoses from prescription medications.Ensysce said that the maximum amount of oxycodone released from PF614-MPAR when three or more doses were taken at one time was reduced compared to that released following the consumption of the same amount of PF614 alone.The company said that the new data demonstrates overdose protection across the full dosage range of PF614-MPAR, which is planned for commercialization. It added that this analysis will be discussed with the U.S. Food and Drug Administration (FDA) in an upcoming meeting.The company will now continue to enroll for parts 2 and 3 of the clinical trial, which will allow it to perfect a final drug product for commercialization.On Stocktwits, retail sentiment around Ensysce Biosciences jumped nine points in the ‘extremely bullish’ territory while message volume remained ‘extremely high.’<figure class="image"><img style="aspect-ratio:1300/298;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_15_at_1_11_30_PM_png_9a122ca00d.webp" alt="ENSC's Sentiment Meter and Message Volume as of 1:30 p.m. ET on April 14, 2025 | Source: Stocktwits" width="1300" height="298"><figcaption>ENSC's Sentiment Meter and Message Volume as of 1:30 p.m. ET on April 14, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expressed optimism about the shares rallying to $6 from their current $2 levels.<stembedurl>https://stocktwits.com/LowFloatSniper/message/611712896</stembedurl><a href="https://stocktwits.com/symbol/ENSC">ENSC stock</a> is down nearly 73% year-to-date and about 78% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/barclays-downgrades-us-auto-sector-owing-to-trump-tariffs/chQRkPFRbOT">Barclays Downgrades US Auto Sector Owing To Trump’s Tariffs: Retail Sentiment Around GM Takes A Plunge</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled

The company stated that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.

Equity

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.

Ensysce Biosciences Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

ENSC
Ensysce Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ENSC News

ENSCEnsysce Biosciences Inc